Drug · DIN 02434806
GAZYVA
SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 28, 2014; first marketed November 28, 2014.
- Drug Identification Number (DIN)
- 02434806
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Obinutuzumab L01FA03
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OBINUTUZUMAB | 25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 25, 2014: NOC 16352New Drug Submission (NDS)